News

Article

AJMC® in the Press, May 10, 2024

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from Memory Care Business referenced a review published in a September 2022 supplement to The American Journal of Managed Care® (AJMC®) focusing on advancing Alzheimer disease treatment. The supplement article, “The Economic and Societal Burden of Alzheimer Disease: Managed Care Considerations,” highlighted that Alzheimer disease treatment could cost an estimated $321 billion in 2022, with costs expected to increase to $1 trillion in 2050.

An article from Business A.M. referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Contributor: In the Misdiagnosis of Menopause, What Needs to Change?” highlighted that 80% of medical residents felt barely comfortable discussing menopause and only 20% of residency programs for obstetrics and gynecology offered menopause training.

Related Videos
Sarah Anderson, oncology strategy lead director, Novotech
Gladys Antelo-Allen
5 experts are featured in this series
5 experts are featured in this series
1 expert is featured in this series.
Jonathan Eisengart, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo